Annual CAPEX
$197.00 K
-$19.00 K-8.80%
31 December 2023
Summary:
Alaunos Therapeutics annual capital expenditures is currently $197.00 thousand, with the most recent change of -$19.00 thousand (-8.80%) on 31 December 2023. During the last 3 years, it has fallen by -$3.13 million (-94.07%). TCRT annual CAPEX is now -97.99% below its all-time high of $9.78 million, reached on 31 December 2020.TCRT CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CAPEX
N/A
30 September 2024
Summary:
Alaunos Therapeutics quarterly capital expenditures is not available.TCRT Quarterly CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CAPEX
N/A
30 September 2024
Summary:
Alaunos Therapeutics TTM capital expenditures is not available.TCRT TTM CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TCRT CAPEX Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | - | - | - |
| 3 y3 years | -94.1% | - | - |
| 5 y5 years | -30.6% | - | - |
TCRT CAPEX High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -98.0% | at low | ||||
| 5 y | 5 years | -98.0% | at low | ||||
| alltime | all time | -98.0% | >+9999.0% |
Alaunos Therapeutics CAPEX History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2023 | $197.00 K(-8.8%) | $0.00(-100.0%) | $197.00 K(-37.1%) |
| Sept 2023 | - | $1000.00(-99.3%) | $313.00 K(-4.0%) |
| June 2023 | - | $135.00 K(+121.3%) | $326.00 K(+31.5%) |
| Mar 2023 | - | $61.00 K(-47.4%) | $248.00 K(+14.8%) |
| Dec 2022 | $216.00 K(-93.5%) | $116.00 K(+728.6%) | $216.00 K(-52.9%) |
| Sept 2022 | - | $14.00 K(-75.4%) | $459.00 K(-43.7%) |
| June 2022 | - | $57.00 K(+96.6%) | $815.00 K(-69.1%) |
| Mar 2022 | - | $29.00 K(-91.9%) | $2.63 M(-20.7%) |
| Dec 2021 | $3.32 M(-66.0%) | $359.00 K(-3.0%) | $3.32 M(-50.6%) |
| Sept 2021 | - | $370.00 K(-80.3%) | $6.73 M(-19.6%) |
| June 2021 | - | $1.88 M(+161.8%) | $8.37 M(-16.1%) |
| Mar 2021 | - | $717.00 K(-81.0%) | $9.98 M(+2.1%) |
| Dec 2020 | $9.78 M(+3343.0%) | $3.77 M(+87.2%) | $9.78 M(+60.0%) |
| Sept 2020 | - | $2.01 M(-42.3%) | $6.11 M(+45.3%) |
| June 2020 | - | $3.49 M(+579.7%) | $4.21 M(+434.6%) |
| Mar 2020 | - | $513.00 K(+413.0%) | $787.00 K(+177.1%) |
| Dec 2019 | $284.00 K(-38.1%) | $100.00 K(-6.5%) | $284.00 K(+189.8%) |
| Sept 2019 | - | $107.00 K(+59.7%) | $98.00 K(-38.8%) |
| June 2019 | - | $67.00 K(+570.0%) | $160.00 K(-49.8%) |
| Mar 2019 | - | $10.00 K(-111.6%) | $319.00 K(-30.5%) |
| Dec 2018 | $459.00 K(-37.7%) | -$86.00 K(-150.9%) | $459.00 K(-44.1%) |
| Sept 2018 | - | $169.00 K(-25.2%) | $821.00 K(+12.8%) |
| June 2018 | - | $226.00 K(+50.7%) | $728.00 K(+37.6%) |
| Mar 2018 | - | $150.00 K(-45.7%) | $529.00 K(-28.2%) |
| Dec 2017 | $737.00 K(+33.8%) | $276.00 K(+263.2%) | $737.00 K(+35.7%) |
| Sept 2017 | - | $76.00 K(+181.5%) | $543.00 K(-20.0%) |
| June 2017 | - | $27.00 K(-92.5%) | $679.00 K(-9.7%) |
| Mar 2017 | - | $358.00 K(+336.6%) | $752.00 K(+36.5%) |
| Dec 2016 | $551.00 K(+33.7%) | $82.00 K(-61.3%) | $551.00 K(-35.6%) |
| Sept 2016 | - | $212.00 K(+112.0%) | $856.00 K(+32.3%) |
| June 2016 | - | $100.00 K(-36.3%) | $647.00 K(+17.2%) |
| Mar 2016 | - | $157.00 K(-59.4%) | $552.00 K(+34.0%) |
| Dec 2015 | $412.00 K(+113.5%) | $387.00 K(>+9900.0%) | $412.00 K(+1548.0%) |
| Sept 2015 | - | $3000.00(-40.0%) | $25.00 K(-78.4%) |
| June 2015 | - | $5000.00(-70.6%) | $116.00 K(-44.2%) |
| Mar 2015 | - | $17.00 K(>+9900.0%) | $208.00 K(+7.8%) |
| Dec 2014 | $193.00 K(+46.2%) | $0.00(-100.0%) | $193.00 K(-6.3%) |
| Sept 2014 | - | $94.00 K(-3.1%) | $206.00 K(+77.6%) |
| June 2014 | - | $97.00 K(+4750.0%) | $116.00 K(+480.0%) |
| Mar 2014 | - | $2000.00(-84.6%) | $20.00 K(-84.8%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2013 | $132.00 K(-91.5%) | $13.00 K(+225.0%) | $132.00 K(-32.7%) |
| Sept 2013 | - | $4000.00(+300.0%) | $196.00 K(-65.4%) |
| June 2013 | - | $1000.00(-99.1%) | $567.00 K(-62.7%) |
| Mar 2013 | - | $114.00 K(+48.1%) | $1.52 M(-2.6%) |
| Dec 2012 | $1.56 M(+34.9%) | $77.00 K(-79.5%) | $1.56 M(-14.9%) |
| Sept 2012 | - | $375.00 K(-60.7%) | $1.83 M(-2.1%) |
| June 2012 | - | $953.00 K(+518.8%) | $1.87 M(+72.8%) |
| Mar 2012 | - | $154.00 K(-56.0%) | $1.08 M(-6.3%) |
| Dec 2011 | $1.16 M(+521.5%) | $350.00 K(-15.5%) | $1.16 M(+33.8%) |
| Sept 2011 | - | $414.00 K(+150.9%) | $864.00 K(+72.8%) |
| June 2011 | - | $165.00 K(-27.3%) | $500.00 K(+23.5%) |
| Mar 2011 | - | $227.00 K(+291.4%) | $405.00 K(+117.7%) |
| Dec 2010 | $186.00 K(+1590.9%) | $58.00 K(+16.0%) | $186.00 K(+36.8%) |
| Sept 2010 | - | $50.00 K(-28.6%) | $136.00 K(+54.5%) |
| June 2010 | - | $70.00 K(+775.0%) | $88.00 K(+388.9%) |
| Mar 2010 | - | $8000.00(0.0%) | $18.00 K(+63.6%) |
| Dec 2009 | $11.00 K(-91.7%) | $8000.00(+300.0%) | $11.00 K(-7.6%) |
| Sept 2009 | - | $2000.00(>+9900.0%) | $11.90 K(-16.8%) |
| June 2009 | - | $0.00(-100.0%) | $14.30 K(-77.5%) |
| Mar 2009 | - | $1000.00(-88.8%) | $63.60 K(-51.8%) |
| Dec 2008 | $132.00 K(-82.1%) | $8900.00(+102.3%) | $132.00 K(-45.7%) |
| Sept 2008 | - | $4400.00(-91.1%) | $243.30 K(-47.6%) |
| June 2008 | - | $49.30 K(-29.0%) | $464.70 K(-21.0%) |
| Mar 2008 | - | $69.40 K(-42.3%) | $588.20 K(-20.3%) |
| Dec 2007 | $738.10 K(+108.3%) | $120.20 K(-46.8%) | $738.20 K(-11.2%) |
| Sept 2007 | - | $225.80 K(+30.7%) | $831.00 K(+28.6%) |
| June 2007 | - | $172.80 K(-21.2%) | $646.40 K(+28.3%) |
| Mar 2007 | - | $219.40 K(+3.0%) | $503.80 K(+42.2%) |
| Dec 2006 | $354.30 K(+172.1%) | $213.00 K(+417.0%) | $354.30 K(+71.2%) |
| Sept 2006 | - | $41.20 K(+36.4%) | $206.90 K(-10.2%) |
| June 2006 | - | $30.20 K(-56.8%) | $230.30 K(+15.8%) |
| Mar 2006 | - | $69.90 K(+6.6%) | $198.80 K(+52.7%) |
| Dec 2005 | $130.20 K(-52.6%) | $65.60 K(+1.5%) | $130.20 K(-36.9%) |
| Sept 2005 | - | $64.60 K(-5069.2%) | $206.20 K(-24.9%) |
| June 2005 | - | -$1300.00(-200.0%) | $274.70 K(-0.5%) |
| Mar 2005 | - | $1300.00(-99.1%) | $276.00 K(+0.5%) |
| Dec 2004 | $274.70 K(>+9900.0%) | $141.60 K(+6.4%) | $274.70 K(+106.4%) |
| Sept 2004 | - | $133.10 K(>+9900.0%) | $133.10 K(>+9900.0%) |
| Dec 2002 | $300.00 | $0.00(-100.0%) | $300.00(0.0%) |
| Sept 2002 | - | $300.00 | $300.00 |
FAQ
- What is Alaunos Therapeutics annual capital expenditures?
- What is the all time high annual CAPEX for Alaunos Therapeutics?
- What is the all time high quarterly CAPEX for Alaunos Therapeutics?
- What is the all time high TTM CAPEX for Alaunos Therapeutics?
What is Alaunos Therapeutics annual capital expenditures?
The current annual CAPEX of TCRT is $197.00 K
What is the all time high annual CAPEX for Alaunos Therapeutics?
Alaunos Therapeutics all-time high annual capital expenditures is $9.78 M
What is the all time high quarterly CAPEX for Alaunos Therapeutics?
Alaunos Therapeutics all-time high quarterly capital expenditures is $3.77 M
What is the all time high TTM CAPEX for Alaunos Therapeutics?
Alaunos Therapeutics all-time high TTM capital expenditures is $9.98 M